Loading people...
Karen Eaton is a biotechnology and healthcare professional who integrates a foundational scientific background in biology with applied business acumen to evaluate emerging medical innovations. While her specific current corporate affiliations and geographic location remain undisclosed, her professional trajectory centers heavily on the intersection of life sciences research and commercial healthcare development. Eaton directs her primary industry focus toward highly specialized technical sectors, actively tracking advancements in complex therapeutic modalities such as cell and gene therapy applications and computational enzyme design. Her broader sector coverage within the medical industry also encompasses the fields of applied immunology, clinical diagnostics, and the engineering of novel health devices. Ultimately, her current focus remains on leveraging this dual scientific and operational expertise to accelerate the commercialization of next-generation healthcare and biotechnology solutions across the broader global medical market.
Karen Eaton is Founder/CEO at Sigma Genetics.
Karen Eaton co-founded Sigma Genetics.